Balloon Guide Catheter to Optimize Outcomes in Stroke Thrombectomy of the Internal Carotid Artery
1 other identifier
interventional
364
1 country
3
Brief Summary
To investigate whether using balloon guide catheter with flow arrest during mechanical thrombectomy, compared to non-flow arrest, improves the rate of first pass expanded Thrombolysis in Cerebral Infarction score (eTICI 2c-3) reperfusion for acute ischemic stroke due to internal carotid artery occlusion
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable stroke
Started Oct 2025
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 8, 2025
CompletedFirst Posted
Study publicly available on registry
September 25, 2025
CompletedStudy Start
First participant enrolled
October 12, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2026
November 17, 2025
November 1, 2025
11 months
September 8, 2025
November 13, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Rate of first-pass reperfusion defined as eTICI 2c-3 reperfusion
Perioperative
Secondary Outcomes (10)
Good outcome proportion, defined as mRS score 0-2
90 days (±7 days) post-procedure
Ordinal Distribution of mRS Scores (mRS Shift analysis)
90 days (±7 days)
Change in stroke severity (NIHSS score)
7 days or discharge (whichever occurs first);
Technical success rate
Perioperative
Final angiographic reperfusion results (eTICI ≥2b, eTICI ≥2c, eTICI 3)
Perioperative
- +5 more secondary outcomes
Study Arms (2)
The experimental group
EXPERIMENTALThe control group
SHAM COMPARATORInterventions
The experimental group will use balloon guide catheter combined with conventional thrombectomy treatment.
use standard guide catheter or neurovascular sheath combined with conventional thrombectomy treatment
Eligibility Criteria
You may qualify if:
- age ≥18 years;
- Clinical diagnosis of acute ischemic stroke with internal carotid artery occlusion confirmed by imaging (CTA/MRA/DSA), including isolated intracranial internal carotid artery (I-type), internal carotid artery intracranial segment involving middle cerebral artery (L-type), or internal carotid artery intracranial segment involving middle and anterior cerebral arteries (T-type) (including tandem embolic occlusions of the internal carotid artery C1 or common carotid artery);
- Baseline NIHSS≥6, and meeting local guidelines for mechanical thrombectomy;
- Time from onset or last known normal to randomization within 24 hours and proceeding to mechanical thrombectomy;
- Signed informed consent (or by legal representative).
You may not qualify if:
- Pre-stroke mRS score \>2
- Intracranial hemorrhage shown on imaging;
- Known or suspected internal carotid artery occlusion caused by dissection or atherosclerosis;
- Vascular tortuosity preventing the use of balloon guide catheter;
- Prior stent implantation in the target vessel that would impede the use or removal of mechanical thrombectomy devices;
- Any other circumstances impeding mechanical thrombectomy implementation;
- Acute occlusion of multiple vascular territories in bilateral anterior circulation or in both the anterior and posterior circulations confirmed by CTA/MRA;
- Pregnant subjects;
- Subjects allergic to contrast agents;
- Subjects refusing to cooperate or unable to tolerate interventional procedures;
- Subjects whose expected lifetime are less than 90 days;
- Midline shift or herniation with ventricular mass effect;
- Subjects deemed unable to participate in follow-up by investigators;
- Other situations deemed unsuitable for balloon guide catheter use by investigators.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
Fujian Medical University Union Hospital
Fuzhou, Fujian, China
Zhangzhou Municipal Hospital
Zhangzhou, Fujian, China
Xuanwu Hospital, Capital Medical University.
Beijing, 100053, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 8, 2025
First Posted
September 25, 2025
Study Start
October 12, 2025
Primary Completion (Estimated)
August 31, 2026
Study Completion (Estimated)
December 31, 2026
Last Updated
November 17, 2025
Record last verified: 2025-11
Data Sharing
- IPD Sharing
- Will not share